ICAM1 and atherosclerosis: SRC-3 depletion or pharmacological inhibition of SRC-3 by bufalin ameliorated atherosclerosis development, at least in part by decreasing endothelial ICAM-1 expression via reduction of NF-κB function (Figure 7).